What The First Half Of 2015 Has Taught Investors

Alessandro Pasetti takes a look at the first half of the year to determine whether any stock could be worth buying ahead of H2.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Fancy a quick recap on the first half of the year? Well, as you might know, it has not been a great ride, but it could have been much worse in this low-yield environment. 


Banks are shaky but their valuations are rising, and if recent trends are anything to go by, their stocks may surprise investors in the second half of the year. If I had to single out one name, that would be HSBC. 

Elsewhere, miners and oil producers might have not bottomed out yet, trends in the first half of the year show, but they look cheap indeed. Anglo American remains one of the cheapest stocks in the sector, while BP is worth at least one pound more than its current valuation, in my view. 

Food retailers are still troubled, while the shares of big consumers and pharmaceuticals companies look a tad pricey, but it would make sense to bet on certain names. For different reasons, Tesco, Unilever and Shire stand out as long-term value plays. 

The Spotlight Is On The Banks 

HSBC (-1.6% year to date) is better than it looks, and most of the bad news that has emerged so far this year is priced into its stock, although management needs to get across its message more clearly.

Standard Chartered (+11%) is bouncing back, and remains a buy for me at this level — under new management, it has made progress in recent months. I am not convinced about Barclays (+13%) and Lloyds (+14.5%), but Royal Bank Of Scotland (-7% year to date) could surprise on the upside — at least if you pay attention to its chief executive’s latest remarks, which point to cast returns to shareholders over time. 

Resources/Food Retailers/Pharma & Consumers 

BP and Shell have only one way to go for their current levels — and that is up, in my view.

I prefer these two names to most miners — Rio Tinto, BHP Billiton, Glencore, Vedanta and so forth — as microeconomic conditions point to a much higher price for Brent, which I think is likely to hit $80 by the end of 2015, but do not provide any encouraging signs for the mining sector. 

Elsewhere, Tesco will likely dominate the headlines for a very long time: it’s not as sound as it once was, of course, but there remains a huge asset base that could be exploited by management, favouring value investors.

Since January, Morrisons and Sainsbury’s have shown that their fortunes depend on positive updates from the market leader, so I’d hold the trigger a bit longer before investing in either stock.

Their fundamentals are not great, but the first half of the year has shown that you may not be in a safe pair of hands with traditionally defensive names, such as AstraZeneca (-7%, and more downside is likely), and Smith & Nephew (-5%, ditto) and a few others, which I flagged as risky investments all over the way. 

In this context, GlaxoSmithKline is flat for the year but looks cheap enough, while Shire (+18% year to date) remains my top pick. Finally, a brief mention for homebuilders such as Persimmon, Taylor Wimpey, Barratt and Berkeley: they have rallied a lot, and it may be safe to take some profit, although their fundamentals are solid and their payouts are attractive. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alessandro Pasetti has no position in any shares mentioned. The Motley Fool UK has recommended shares in GlaxoSmithKline, HSBC, Barclays, Centrica, Berkeley Group, and owns shares in Tesco and Unilever. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Jumbo jet preparing to take off on a runway at sunset
Investing Articles

Down 70%+ since 2020, is IAG’s share price an unmissable bargain?

IAG’s share price is still down around 73% from its pre-Covid level, but with the business performing well last year,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

£17,000 of shares in the FTSE 100 dividend giant can make me £18,874 every year in passive income!

This FTSE 100 dividend superstar has an 8.8% yield with dividends projected to rise. It looks very undervalued to me…

Read more »

Investing Articles

2 top UK growth stocks I’m buying for my Stocks and Shares ISA in July

Looking for UK-listed growth firms to add to a Stocks and Shares ISA? Our writer highlights two he's planning to…

Read more »

artificial intelligence investing algorithms
Investing Articles

This overvalued growth stock makes Nvidia look cheap!

ARM Holdings is a growth stock that’s benefitted from the AI rally. Muhammad Cheema takes a look at whether this…

Read more »

Investing Articles

1 penny stock I’d buy today while it’s 63p

This penny stock's down 70% since last March, yet could be set for a big comeback as the firm rebuilds…

Read more »

Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
Investing Articles

Buying 8,617 Legal & General shares would give me a stunning income of £1,840 a year

Legal & General shares offer one of the highest dividend yields on the entire FTSE 100. Harvey Jones wants to…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

£25k to invest? Here’s how I’d try to turn that into a second income of £12,578 a year!

If Harvey Jones had a lump sum to invest today he'd go flat out buying top FTSE 100 second income…

Read more »

Union Jack flag in a castle shaped sandcastle on a beautiful beach in brilliant sunshine
Investing Articles

2 lesser-known dividend stocks to consider this summer

Summer is here and global markets could be heading for a period of subdued trading. But our writer thinks there…

Read more »